Tuesday, August 11, 2020 3:58:22 PM
Aviptadil now being prescribed in India!
❗️Off-label use of RLF 100 in India.
— Siddhartha| सिद्धार्थ| సిద్ధార్థ (@das_seed) August 11, 2020
NeuroRx has been granted Investigational New Drug (IND) permission by @US_FDA to test RLF-100 for inhaled use in patients with moderate and severe #COVID19 in order to prevent progression to respiratory failure. 🧐
Image via @sandhyafernez pic.twitter.com/jMOcCrTq8A
Disclaimer.
I am not a professional investment adviser. All things I post are in my own opinion and not advice to buy, sell or trade any stock, security or anything else for that matter. My posts are made in the form of anecdotes.
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
